Ahmad Elbash, MD
Interventional Cardiology · Richmond, INNPI 1770797466
Payments from drug & device makers
What this record shows
This record is dominated by other: $38,250 of the $48,184 with a category attached, or 79.4%. Angiodynamics, Inc. accounts for 81.7% of it on its own, with 39 other manufacturers making up the rest. 2025 is the largest year on record at $30,778, more than ten times the $1,321 reported in 2019. Among interventional cardiology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 296 payments — averaging $162.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$39K
- Edwards Lifesciences$2K
- Boston Scientific$1K
- Inari Medical, Inc.$979
- Celonova Biosciences, Inc.$880
- AstraZeneca$683
- plus $3K from 34 others
What the payments were for
- Consulting fees$1,3503%
- Travel & lodging$7001%
- Food & beverage$7,88416%
- Other$38,25079%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$48,184 in reported general payments places this provider in the 90th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 213 | $187,500 |
| Repatha SureclickEvolocumab | 147 | $130,386 |
| EliquisApixaban | 140 | $107,162 |
| JardianceEmpagliflozin | 88 | $82,548 |
| XareltoRivaroxaban | 56 | $48,445 |
| VascepaIcosapent Ethyl | 72 | $32,615 |
| FarxigaDapagliflozin Propanediol | 29 | $29,413 |
| BrilintaTicagrelor | 33 | $25,911 |
| Potassium Chloride | 239 | $2,481 |
| Midodrine Hcl | 33 | $2,126 |
| Metoprolol Succinate | 251 | $1,946 |
| Atorvastatin Calcium | 245 | $1,453 |
| Ranolazine ErRanolazine | 29 | $1,446 |
| Nitroglycerin | 95 | $1,415 |
| ClopidogrelClopidogrel Bisulfate | 177 | $1,250 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $580 | $187,500213 claims |
| PfizerEliquis | $207 | $107,162140 claims |
| Boehringer IngelheimJardiance | $106 | $82,54888 claims |
| AstraZenecaFarxiga, Brilinta | $683 | $55,32462 claims |
| Johnson & JohnsonXarelto | $179 | $48,44556 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 170 interventional cardiology providers in Indiana.
Other interventional cardiology in Richmond
- Samer AbbasEast Chicago$395K
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Muzammil MusaniFort Wayne$184K
- Dean FerreraEast Chicago$180K
- Shashidhar DivakaruniMunster$97K
- Jarrod FrizzellEvansville$86K
- Navneet LatherNoblesville$83K
- Michael BallIndianapolis$76K
- Ezequiel Munoz GonzalezCarmel$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.